Multielectrode Radiofrequency Balloon for Atrial Fibrillation Catheter Ablation: A Multicenter Real-World Experience

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) Heliostar (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• symptomatic atrial fibrillation with indication to catheter ablation

Locations
Other Locations
Belgium
UZ Brussel Heart Rhythm Management Center
RECRUITING
Brussels
Contact Information
Primary
Alexandre Almorad, MD
alexandre.almorad@uzbrussel.be
+32 2 4776009
Time Frame
Start Date: 2021-01-01
Estimated Completion Date: 2030-12-01
Participants
Target number of participants: 2000
Related Therapeutic Areas
Sponsors
Leads: Universitair Ziekenhuis Brussel

This content was sourced from clinicaltrials.gov